Postoperative Pain and Analgesic Requirements After Preoperative Methadone for Primary TKA
Key facts
- Who runs it
- University of Louisville
- Where
- Louisville, United StatesSee the site
- Trial code
- Status
- Completed
- Phase
- Phase 4
- People taking part
- 150 people enrolled
- Started
- 19 Feb 2024
- Ended
- 18 Oct 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Preoperative Methadone
- Preoperative Oxycodone
- Record updated
- 15 November 2024
Who can take part
- Age
- 21 years to 89 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Patient age is 21-89 at time of surgery
- Patient is scheduled to undergo a unilateral primary TKA, secondary to osteoarthritis
- Patient agrees to participate as a study subject and signs the Informed Consent and Research Authorization document
- Patient is able to read and speak English
Who cannot take part
- History of liver or kidney disease,
- Hypersensitivity to methadone
- Patient is under the age of 21
- Patient's primary diagnosis is not osteoarthritis
- Patient is unable to read and speak English
- Known or suspected GI obstruction
- Patients with significant respiratory depression
- Pregnant or nursing females
Where in United States
- UofL HealthLouisville, United States
About the trial
What the trial wants to find out
The goal of this prospective, randomized study is to compare the outcomes of two cohorts of patients undergoing primary Total Knee Arthroplasty (TKA) and to determine whether a single dose of methadone administered preoperatively is effective at reducing postoperative opioid usage and postoperative pain versus a control group of patients receiving standard intraoperative opioids only for primary TKA.
Read full original descriptionShow less
The main questions it aims to answer are:
* What is the efficacy of a single preoperative dose of methadone in reducing opioid consumption and postoperative pain in primary total knee arthroplasty? * Will the study results demonstrate the effectiveness and safety of a single preoperative dose of methadone (10 mg) in primary total knee arthroplasty in reducing postoperative opioid usage while maintaining a similar or better level of pain control when compared to a standard pain control regimen? Researchers will compare Methadone to a standard pain control regimen (Oxycodone) to see if Methadone is equivalent or more effective at reducing opioid consumption and postoperative pain in primary total knee arthroplasty
Participants will:
* be randomized into one of two groups * undergo a primary TKA * complete a tracking sheet documenting daily pain medicine usage and VAS pain level for the first 14 days following the TKA * return to office at 2 weeks and 6 weeks postop for follow-up * complete additional questionnaires at 2 weeks and 6 weeks postop
The 2 groups in the trial
- Methadone GroupTreatment being tested
Participant receives a one-time preoperative dose of 10 mg of methadone
Treatment: Preoperative Methadone
- Oxycodone GroupExisting treatment, for comparison
participant receives a one-time preoperative dose of 10 mg of oral oxycodone
Treatment: Preoperative Oxycodone
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Postoperative Pain and Analgesic Requirements After Preoperative Methadone for Primary Total Knee Arthroplasty, a Prospective, Randomized Study
- Record updated
- 15 November 2024